Method and apparatus for distinguishing Crohn's disease from ulcerative colitis and other gastrointestinal diseases by detecting the presence of fecal antibodies to Saccharomyces cerevisiae
Abstract
A method and apparatus for the differentiation of Crohn's disease from other gastrointestinal illnesses, such as ulcerative colitis and irritable bowel syndrome, using the presence of fecal anti-Saccharomyces cerevisiae antibodies (ASCA) as a marker for Crohn's disease are provided. The apparatus includes an enzyme-linked immunoassay or other immunoassay that utilizes antibodies specific to human immunoglobins for the measurement of total endogenous ASCA in a human fecal sample. The method and apparatus may be used by healthcare providers to distinguish Crohn's disease from other gastrointestinal illnesses, such as ulcerative colitis and irritable bowel syndrome.
Claims
exact text as granted — not AI-modified1 . A kit for diagnosing Crohn's disease by testing a fecal sample from a person to be diagnosed, the kit comprising:
one or more microassay plates, each the plate containing extract Saccharomyces cerevisiae; enzyme-linked polyclonal antibody to human anti- Saccharomyces cerevisiae antibodies; and enzyme substrate for color development.
2 . The kit as recited in claim 1 , further comprising purified human anti- Saccharomyces cerevisiae antibodies as a positive control.
3 . The kit as recited in claim 1 , further comprising a stop solution for quenching the reaction.
4 . The kit as recited in claim 2 , further comprising a stop solution for quenching the reaction.Join the waitlist — get patent alerts
Track US2005136495A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.